Conformis, Medacta settle patent litigation


Conformis and Medacta reached a settlement in a patent dispute, the devicemakers said.

Under the settlement, Medacta will receive a non-exclusive license to some Conformis patents related to patient-specific instruments with knee and shoulder implants, Conformis said Nov. 14. Medacta on Nov. 15 said the settlement also "contemplates the payment of a sum in a low single digit million-dollar amount."

"Through this settlement, we have once again monetized our patient-specific instrument patents and steadfastly protected our patient-specific implant products and services," Conformis President and CEO Mark Augusti said in a statement.

Copyright © 2023 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Podcast

Featured Whitepapers